Catalyst Wire Dossier Catalyst Wire Dossier

LAYLA

· PMG Pharm Co., Ltd
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LAYLA, covering 2013-10-14 to 2017-09-20. Get the full timeline:

Most recent: Clinical Trial Update: To Compare the Efficacy and Safety of LAYLA in Osteoarthritis Patients of the Knee [Phase 4]

See pricing